Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nabi and GSK close NicVAX option and license agreement

March 9, 2010

Nabi stockholders approve NicVAX option and license agreement

March 4, 2010

BTG and Paladin complete agreement for DigiFab for digoxin toxicity

Feb. 26, 2010

Cleveland BioLabs responds to Department of Defense RFP for CBLB-502

Feb. 25, 2010

Catalyst and NIDA to initiate phase IIb trial of CPP-109 for cocaine addiction

Feb. 24, 2010

Embera and Exponential sign clinical development agreement for EMB-001C

Feb. 17, 2010

Pregabalin shows potential as a treatment for alcohol withdrawal syndrome

Feb. 8, 2010

Swissmedic approves BTG's DigiFab for life-threatening digitalis intoxication

Feb. 5, 2010

Oxytocin attenuates methamphetamine self-administration in rats

Feb. 4, 2010

Beta-lactam antibiotic ceftriaxone reduces cocaine-seeking behavior in rats

Jan. 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...